F/M Emerald Life Sciences Innovation ETF (LFSC)
NASDAQ: LFSC · Real-Time Price · USD
23.09
-0.30 (-1.27%)
At close: May 13, 2025, 4:00 PM
23.09
0.00 (0.00%)
After-hours: May 13, 2025, 4:15 PM EDT
LFSC Holdings List
As of May 9, 2025
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | SLNO | Soleno Therapeutics, Inc. | 7.77% |
| 2 | BBIO | BridgeBio Pharma, Inc. | 7.06% |
| 3 | LIVN | LivaNova PLC | 6.48% |
| 4 | BPMC | Blueprint Medicines Corporation | 6.46% |
| 5 | RDNT | RadNet, Inc. | 6.44% |
| 6 | TMDX | TransMedics Group, Inc. | 5.95% |
| 7 | TVTX | Travere Therapeutics, Inc. | 5.90% |
| 8 | MMSI | Merit Medical Systems, Inc. | 5.29% |
| 9 | COLL | Collegium Pharmaceutical, Inc. | 4.48% |
| 10 | ATEC | Alphatec Holdings, Inc. | 4.19% |
| 11 | RARE | Ultragenyx Pharmaceutical Inc. | 4.09% |
| 12 | MDGL | Madrigal Pharmaceuticals, Inc. | 3.52% |
| 13 | INSM | Insmed Incorporated | 3.40% |
| 14 | ETNB | 89bio, Inc. | 3.31% |
| 15 | GH | Guardant Health, Inc. | 3.22% |
| 16 | WVE | Wave Life Sciences Ltd. | 3.16% |
| 17 | ACAD | ACADIA Pharmaceuticals Inc. | 2.40% |
| 18 | AKRO | Akero Therapeutics, Inc. | 2.28% |
| 19 | KALV | KalVista Pharmaceuticals, Inc. | 1.69% |
| 20 | UTHR | United Therapeutics Corporation | 1.53% |
| 21 | GMED | Globus Medical, Inc. | 1.50% |
| 22 | SYRE | Spyre Therapeutics, Inc. | 1.46% |
| 23 | SVRA | Savara Inc. | 1.27% |
| 24 | NVCR | NovoCure Limited | 1.18% |
| 25 | RBIL | F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF | 1.04% |
| 26 | ITGR | Integer Holdings Corporation | 1.01% |
| 27 | CORT | Corcept Therapeutics Incorporated | 1.00% |
| 28 | OFIX | Orthofix Medical Inc. | 0.90% |
| 29 | BHVN | Biohaven Ltd. | 0.87% |
| 30 | NEO | NeoGenomics, Inc. | 0.74% |
| 31 | MURA | Mural Oncology plc | 0.40% |
| 32 | n/a | U.S. Bank Money Market Deposit Account | 0.00% |
| 33 | n/a | US DOLLARS | -0.00% |
| 34 | n/a | DEPOSITS WITH BROKER FOR SHORT POSITIONS | -0.02% |
As of May 9, 2025